Watson names new CFO
This article was originally published in Scrip
Mark Durand, Watson Pharmaceuticals' chief financial officer and senior vice-president, has left the company for personal reasons. He will be succeeded by Todd Joyce. Mr Joyce joined Watson in 1997 as corporate controller, and was named vice-president, corporate controller and treasurer in 2001. From October 2006 to November 2007, he served as interim principal financial officer.